AccessPak for HIV PEP Expanded with Kaletra and Natalizumab Intravenous
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Natalizumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: natalizumab
Brand name: Tysabri
Synonyms: Natalizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Natalvirt 90 DHA
- AccessPak for HIV PEP Expanded with Kaletra-Natalvirt CA
- AccessPak for HIV PEP Expanded with Kaletra-Natazia
- AccessPak for HIV PEP Expanded with Kaletra-Nateglinide
- AccessPak for HIV PEP Expanded with Kaletra-Natelle Complete
- AccessPak for HIV PEP Expanded with Kaletra-Natelle One
- Natalizumab Intravenous-AccessPak for HIV PEP Expanded with Viracept
- Natalizumab Intravenous-Accolate
- Natalizumab Intravenous-Accretropin
- Natalizumab Intravenous-Accucaine
- Natalizumab Intravenous-AccuHist Drops
- Natalizumab Intravenous-AccuHist PDX Drops